New — Free Peptide Starter Guide (2026): 13 chapters, 34 cited studies

Get it free
ToolsCompareKPV vs Ovagen

KPV vs Ovagen

Side-by-side comparison of key properties, dosing, and research.

Immune SupportRecovery & Repair
KPV
Anti-Aging & Longevity
Ovagen
Summary
KPV is a naturally occurring anti-inflammatory tripeptide derived from the C-terminal of alpha-MSH. It powerfully suppresses intestinal and systemic inflammation via melanocortin receptors, making it valuable for IBD, gut healing, and wound repair.
Ovagen is a tripeptide bioregulator (Glu-Asp-Leu) developed by Professor Vladimir Khavinson, primarily targeting liver tissue. It supports hepatocyte function, liver cell regeneration, and protection against hepatic aging and disease. Ovagen is used in protocols for chronic liver disease, hepatoprotection, and metabolic liver conditions including fatty liver disease.
Half-Life
Short half-life (~15–30 minutes), but effects persist longer due to receptor-level anti-inflammatory cascades
Short (minutes); sustained gene-regulatory effects
Admin Route
Oral, SubQ, Topical
SubQ, Oral
Research
Typical Dose
500 mcg – 1 mg
10 mg per day
Frequency
Once to twice daily
Daily for 10–30 days
Key Benefits
  • Reduces intestinal inflammation (IBD, Crohn's, colitis)
  • Promotes gut mucosal healing and barrier integrity
  • Accelerates wound healing topically
  • Suppresses systemic inflammatory cytokines
  • Antimicrobial properties against pathogens
  • Reduces neuroinflammation when administered systemically
  • May improve symptoms of inflammatory skin conditions
  • Hepatoprotective effects against toxic, viral, and metabolic liver damage
  • Promotes hepatocyte regeneration and liver tissue repair
  • May reduce liver fibrosis progression
  • Supports liver metabolic function and detoxification capacity
  • Anti-aging effects on hepatic tissue
  • Useful in NAFLD/MASH supportive protocols
  • Compatible with NAD+, glutathione, and BPC-157 in liver health stacks
Side Effects
  • Generally very well tolerated
  • Mild injection site reactions (SC)
  • Rare: transient flushing
  • Generally well tolerated
  • Mild injection site reactions
  • No clinically significant hepatotoxicity reported
Stacks With